Nuisance Compounds, PAINS Filters, and Dark Chemical Matter in the GSK HTS Collection

Author:

Chakravorty Subhas J.1,Chan James23,Greenwood Marie Nicole2,Popa-Burke Ioana45,Remlinger Katja S.6,Pickett Stephen D.7,Green Darren V. S.7,Fillmore Martin C.8,Dean Tony W.8,Luengo Juan I.910,Macarrón Ricardo2

Affiliation:

1. GlaxoSmithKline R&D Pharmaceuticals, Computational Chemistry, Collegeville, PA, USA

2. GlaxoSmithKline R&D Pharmaceuticals, Sample Management Technologies, Collegeville, PA, USA

3. Retired, PA, USA

4. GlaxoSmithKline R&D Pharmaceuticals, Sample Management Technologies, Research Triangle Park, NC, USA

5. Sandoz, Munich, Germany

6. GlaxoSmithKline R&D Pharmaceuticals, Statistical Sciences, Research Triangle Park, NC, USA

7. GlaxoSmithKline R&D Pharmaceuticals, Computational Chemistry, Stevenage, UK

8. GlaxoSmithKline R&D Pharmaceuticals, Medicinal Chemistry, Stevenage, UK

9. GlaxoSmithKline R&D Pharmaceuticals, Medicinal Chemistry, Collegeville, PA, USA

10. Prelude Therapeutics, Newark, DE, USA

Abstract

High-throughput screening (HTS) hits include compounds with undesirable properties. Many filters have been described to identify such hits. Notably, pan-assay interference compounds (PAINS) has been adopted by the community as the standard term to refer to such filters, and very useful guidelines have been adopted by the American Chemical Society (ACS) and subsequently triggered a healthy scientific debate about the pitfalls of draconian use of filters. Using an inhibitory frequency index, we have analyzed in detail the promiscuity profile of the whole GlaxoSmithKline (GSK) HTS collection comprising more than 2 million unique compounds that have been tested in hundreds of screening assays. We provide a comprehensive analysis of many previously published filters and newly described classes of nuisance structures that may serve as a useful source of empirical information to guide the design or growth of HTS collections and hit triaging strategies.

Publisher

Elsevier BV

Subject

Molecular Medicine,Biochemistry,Analytical Chemistry,Biotechnology

Cited by 48 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3